Aripiprazol Actavis 5 mg
Aripiprazol Actavis 5 mg is a medicine authorised by Swissmedic under authorisation number 65428. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 2015 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 65428 |
|---|---|
| Name | Aripiprazol Actavis 5 mg |
| Full name | Aripiprazol Actavis 5 mg, Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 16 December 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Aripiprazol Actavis 5 mg, Tabletten | B | 16 December 2015 |
| 2 | Aripiprazol Actavis 10 mg, Tabletten | B | 16 December 2015 |
| 3 | Aripiprazol Actavis 15 mg, Tabletten | B | 16 December 2015 |
| 4 | Aripiprazol Actavis 30 mg, Tabletten | B | 16 December 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Aripiprazol Actavis 5 mg authorised in Switzerland?
Yes. Aripiprazol Actavis 5 mg is authorised by Swissmedic under authorisation number 65428, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Aripiprazol Actavis 5 mg have?
Aripiprazol Actavis 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Aripiprazol Actavis 5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.